Literature DB >> 19345448

[Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients].

A-S Delelis-Fanien1, F Séité, M Priner, M Paccalin.   

Abstract

INTRODUCTION: There is no compulsory vaccination in the adult population. Therefore, vaccine coverage appears heterogeneous.
METHODS: We performed a 2-month survey to evaluate the vaccine coverage administered by 11 general practitioners in their patients aged 65 and over, with a focus on influenza vaccination recommended in France for individuals being 65 years old or more and on pneumococcal vaccination indicated but not recommended in the same age population; analysing the reasons for non vaccine administration against influenza and pneumococcal infections.
RESULTS: Two hundred and ninety-nine patients were interviewed, mean age of 77+/-6,9 years; 76,3% were vaccinated against influenza; only nine patients out of the 46 having a recommendation for pneumococcal vaccine were immunized (19,6%). The main reasons for non vaccination were the fear of vaccine for influenza and a lack of information for the pneumococcal vaccine.
CONCLUSION: These results underline the low prevalence for pneumococcal vaccine in ambulatory patients, despite recommendations. Previous studies with controversial data might explain the low prevalence. Better information of the expected benefit of this vaccine and better correlation between indications and recommendations could increase its coverage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345448     DOI: 10.1016/j.revmed.2008.12.026

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  5 in total

1.  Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia.

Authors:  Angel Vila-Corcoles; Olga Ochoa-Gondar; Imma Hospital; Cinta de Diego; Eva Satué; Jordi Bladé; Xabier Ansa; Jorge A Guzmán; Elisabet Salsench; Francisca Ramos
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

2.  Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease.

Authors:  Jacques Gaillat; Amine Benadji; Xavier Duval; Kostas Danis; Bruno Hoen; Bernard Page; Guillaume Béraud; Véronique Vernet-Garnier; Christophe Strady; Nathalie Brieu; Laurence Maulin; Carine Roy; Marie-Cécile Ploy; Emmanuelle Varon; Sarah Tubiana
Journal:  Infection       Date:  2021-09-01       Impact factor: 3.553

Review 3.  Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Authors:  Susanna Esposito; Paolo Bonanni; Stefania Maggi; Litjan Tan; Filippo Ansaldi; Pier Luigi Lopalco; Ron Dagan; Jean-Pierre Michel; Pierre van Damme; Jacques Gaillat; Roman Prymula; Timo Vesikari; Cristina Mussini; Uwe Frank; Albert Osterhaus; Lucia Pastore Celentano; Marta Rossi; Valentina Guercio; Gaetan Gavazzi
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

4.  Pneumococcal Vaccination Coverage and Uptake Among Adults in Switzerland: A Nationwide Cross-Sectional Study of Vaccination Records.

Authors:  Kyra D Zens; Vasiliki Baroutsou; Jan S Fehr; Phung Lang
Journal:  Front Public Health       Date:  2022-01-31

5.  Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners.

Authors:  Ludivine Privileggio; Alessandra Falchi; Marie-Lise Grisoni; Cécile Souty; Clément Turbelin; Laure Fonteneau; Thomas Hanslik; Solen Kernéis
Journal:  BMC Public Health       Date:  2013-03-20       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.